They found evidence of brain inflammation, documented by elevations of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in a severity dependent manner, not only during acute disease but still persistent at follow-up 4 months later [99]. Here, GFAP is linked to brain inflammatory disease.